Vertex Pharmaceuticals: Q2 Earnings Insights

Vertex Pharmaceuticals: Q2 Earnings Insights

Vertex Pharmaceuticals VRTX reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Vertex Pharmaceuticals beat estimated earnings by 2.27%, reporting an EPS of $3.6 versus an estimate of $3.52.

Revenue was up $403.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 4.67% drop in the share price the next day.

Here's a look at Vertex Pharmaceuticals's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 3.49 3.29 3.08 2.28
EPS Actual 3.52 3.37 3.56 3.11
Revenue Estimate 2.08B 2.00B 1.86B 1.72B
Revenue Actual 2.10B 2.07B 1.98B 1.79B

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 3.49 3.29 3.08 2.28
EPS Actual 3.52 3.37 3.56 3.11
Revenue Estimate 2.08B 2.00B 1.86B 1.72B
Revenue Actual 2.10B 2.07B 1.98B 1.79B

To track all earnings releases for Vertex Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings